Suppr超能文献

人类 NK 细胞-少突胶质细胞界面上的 KIR2DL4-HLAG 相互作用调节 IFN-γ 介导的作用。

KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.

机构信息

Baylor College of Medicine, 1 Baylor Plaza, Houston, TX-77030, USA; Center for Human Immunobiology, Texas Children's Hospital, 1102 Bates St, Houston, TX, 77030, USA.

Center for Human Immunobiology, Texas Children's Hospital, 1102 Bates St, Houston, TX, 77030, USA.

出版信息

Mol Immunol. 2019 Nov;115:39-55. doi: 10.1016/j.molimm.2018.09.027. Epub 2018 Nov 24.

Abstract

Interactions between germline-encoded natural killer (NK) cell receptors and their respective ligands on tumorigenic or virus-infected cells determine NK cell cytotoxic activity and/or cytokine secretion. NK cell cytokine responses can be augmented in and can potentially contribute to multiple sclerosis (MS), an inflammatory disease of the central nervous system focused upon the oligodendrocytes (OLs). To investigate mechanisms by which NK cells may contribute to MS pathogenesis, we developed an in vitro human model of OL-NK cell interaction. We found that activated, but not resting human NK cells form conjugates with, and mediate cytotoxicity against, human oligodendrocytes. NK cells, when in conjugate with OLs, rapidly synthesize and polarize IFN-γ toward the OLs. IFN-γ  is capable of reducing myelin oligodendrocyte and myelin associated glycoproteins (MOG and MAG) content. This activity is independent of MHC class-I mediated inhibition via KIR2DL1, but dependent upon the interaction between NK cell-expressed KIR2DL4 and its oligodendrocyte-expressed ligand, HLA-G. NK cells from patients with MS express higher levels of IFN-γ following conjugation to OLs, more actively promote in vitro reduction of MOG and MAG and have higher frequencies of the KIR2DL4 positive population. These data collectively suggest a mechanism by which NK cells can promote pathogenic effects upon OLs.

摘要

天然杀伤 (NK) 细胞受体与肿瘤发生或病毒感染细胞上的相应配体之间的相互作用决定了 NK 细胞的细胞毒性活性和/或细胞因子分泌。NK 细胞的细胞因子反应可以增强,并可能有助于多发性硬化症 (MS),这是一种中枢神经系统的炎症性疾病,主要针对少突胶质细胞 (OLs)。为了研究 NK 细胞如何有助于 MS 发病机制,我们开发了 OL-NK 细胞相互作用的体外人类模型。我们发现,活化的而不是静止的人类 NK 细胞与人类少突胶质细胞形成共轭,并介导对其的细胞毒性。NK 细胞与 OL 共轭时,会迅速合成并将 IFN-γ 向 OL 极化。IFN-γ 能够减少髓鞘少突胶质细胞和髓鞘相关糖蛋白 (MOG 和 MAG) 的含量。这种活性独立于 MHC 类-I 通过 KIR2DL1 介导的抑制,但依赖于 NK 细胞表达的 KIR2DL4 与其少突胶质细胞表达的配体 HLA-G 之间的相互作用。与 OL 共轭后,来自 MS 患者的 NK 细胞表达更高水平的 IFN-γ,更积极地促进体外 MOG 和 MAG 的减少,并且具有更高比例的 KIR2DL4 阳性群体。这些数据共同表明 NK 细胞可以促进 OL 产生致病性影响的机制。

相似文献

1
KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.
Mol Immunol. 2019 Nov;115:39-55. doi: 10.1016/j.molimm.2018.09.027. Epub 2018 Nov 24.
2
Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
J Immunol. 2014 Jan 15;192(2):732-40. doi: 10.4049/jimmunol.1301748. Epub 2013 Dec 11.
3
Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.
Signal Transduct Target Ther. 2021 Jun 23;6(1):236. doi: 10.1038/s41392-021-00629-w.
8
β2-Microglobulin-free HLA-G activates natural killer cells by increasing cytotoxicity and proinflammatory cytokine production.
Hum Immunol. 2013 Apr;74(4):417-24. doi: 10.1016/j.humimm.2012.11.022. Epub 2012 Dec 7.
9
NK cell-mediated lysis of autologous human oligodendrocytes.
J Neuroimmunol. 2001 May 1;116(1):107-15. doi: 10.1016/s0165-5728(01)00289-2.
10
HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction.
Cell Mol Immunol. 2014 Sep;11(5):460-6. doi: 10.1038/cmi.2014.53. Epub 2014 Jul 7.

引用本文的文献

1
Blood metabolites as mediators in erectile dysfunction: insights from a multi-center proteomics and genetic study.
Front Pharmacol. 2025 Jun 2;16:1568780. doi: 10.3389/fphar.2025.1568780. eCollection 2025.
3
NK Cells in Autoimmune Diseases: Protective or Pathogenic?
Front Immunol. 2021 Mar 12;12:624687. doi: 10.3389/fimmu.2021.624687. eCollection 2021.

本文引用的文献

1
Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes.
Eur J Neurol. 2019 Jan;26(1):175-183. doi: 10.1111/ene.13791. Epub 2018 Oct 15.
3
Infectious agents and different course of multiple sclerosis: a systematic review.
Acta Neurol Belg. 2018 Sep;118(3):361-377. doi: 10.1007/s13760-018-0976-y. Epub 2018 Jul 13.
4
The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity.
Front Immunol. 2018 May 30;9:1219. doi: 10.3389/fimmu.2018.01219. eCollection 2018.
6
Recent developments in interferon-based therapies for multiple sclerosis.
Expert Opin Biol Ther. 2018 Jun;18(6):665-680. doi: 10.1080/14712598.2018.1462793. Epub 2018 Apr 20.
7
Demyelination with preferential MAG loss: A complex message from MS paraffin blocks.
J Neurol Sci. 2018 Feb 15;385:126-130. doi: 10.1016/j.jns.2017.12.029. Epub 2017 Dec 24.
8
The immunogenetics of neurological disease.
Immunology. 2018 Apr;153(4):399-414. doi: 10.1111/imm.12869. Epub 2017 Dec 11.
9
Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.
Eur J Immunol. 2018 Feb;48(2):380-383. doi: 10.1002/eji.201747277. Epub 2017 Dec 15.
10
CCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis.
Front Immunol. 2017 Sep 4;8:1079. doi: 10.3389/fimmu.2017.01079. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验